Paul H. Lange

NCCN Urothelial Cancer Practice Guidelines

James M. Kozlowski, Jerome P. Richie, Howard I. Scher, 1998 .

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Andrew J. Vickers, James L. Mohler, Geoffrey A. Sonn, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

Stephen J. Salipante, Deborah A. Nickerson, Jay Shendure, 2011, Proceedings of the National Academy of Sciences.

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

Lawrence D. True, Peter S. Nelson, Celestia S. Higano, 2007, Clinical & Experimental Metastasis.

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Jerome P. Richie, Alan W. Partin, Peter T. Scardino, 1998, JAMA.